William W Van Osdol

Title: **William W. Van Osdol: Innovator in Controlled Release Oral Dosage Forms**

Introduction

William W. Van Osdol is a prominent inventor based in Mountain View, California, recognized for his significant contributions to the field of pharmaceuticals. With a total of five patents to his name, he has played a crucial role in developing controlled release oral dosage forms, particularly for the treatment of Attention Deficit Disorder (ADD) and Attention Deficit Hyperactivity Disorder (ADHD). His innovative ideas have paved the way for more effective and safer medications.

Latest Patents

Among his most notable patents are those focusing on controlled release oral dosage forms suitable for the administration of methylphenidate. These patents include abuse-resistant formulations and methods for treating ADD and ADHD using these oral dosage forms. His work aims to improve the efficacy of treatments while minimizing the potential for abuse, ultimately enhancing patient care.

Career Highlights

Throughout his career, William W. Van Osdol has held key positions at various reputable organizations, including Durect Corporation and Alza Corporation. His experiences at these companies have allowed him to hone his skills in pharmaceutical development and innovation.

Collaborations

William has collaborated with talented individuals such as Jan Jozef Scicinski and Huey-Ching Su. These partnerships have fostered an environment of creativity and shared expertise, leading to groundbreaking advancements in pharmaceutical technologies.

Conclusion

William W. Van Osdol’s innovative spirit and dedication to improving pharmaceutical care continue to make an impact on the field. His contributions to controlled release oral dosage forms demonstrate the importance of patient-centered solutions in the treatment of ADD and ADHD. As the landscape of pharmaceuticals evolves, innovators like Van Osdol remain at the forefront, paving the way for safer and more effective therapies.